You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Adalimumab for treating moderate to severe plaque psoriasis

  • Technology appraisal guidance
  • Reference number: TA146
  • Published:  25 June 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members and NICE project team
  • 8 Sources of evidence considered by the Committee
  • 9 Update information

9 Update information

November 2025: We have made minor editorial changes to the wording in section 1.1 to align with the NICE guideline on psoriasis: assessment and management. This does not affect the meaning or intent of the guidance.

ISBN: 978-1-4731-6646-2


Previous page 8 Sources of evidence considered by the Committee
Back to top